S. 2944 · 108th Congress
A bill to provide that no funds may be expended by the United States Trade Representative to negotiate data exclusivity provisions for certain pharmaceutical products.
- Stage
- In committee
- Sponsor
- Ron Wyden
- Introduced
- 2004-10-08
- Latest action
- 2004-10-08 · Introduced in Senate
Subjects
Health
Foreign trade and international finance
Commerce
Office of the U.S. Trade Representative
Emergency Management
Government Operations and Politics
Emergency medicine
International Affairs
Trade agreements
Trade negotiations
Drug approvals
Drugs
AIDS (Disease)
Malaria
Tuberculosis
Human immunodeficiency viruses
Epidemics
Drug industry
Generic drugs
Clinical trials